|
|
camera type eye development
|
GO:0043010 |
266 |
0.274
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.166
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.145
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.137
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.115
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.108
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.106
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.102
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.097
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.095
|
|
|
|
menarche
|
GO:0042696 |
1 |
0.094
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.093
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.092
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.091
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.089
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.088
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.088
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.087
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.084
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.082
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.079
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.078
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.078
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.074
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.074
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.073
|
|
|
|
retinal cone cell development
|
GO:0046549 |
8 |
0.073
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.069
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.068
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.067
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.065
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.065
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.064
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.064
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.061
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.059
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.058
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.057
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.057
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.055
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.055
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.055
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.055
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.053
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.053
|
Mouse |
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.053
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.051
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.051
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.051
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.050
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.050
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.049
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.049
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.049
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.048
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.048
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.048
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.048
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.048
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.047
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.046
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.045
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.045
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.045
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.045
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.045
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.045
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.044
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.044
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.044
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.044
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.044
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.044
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.044
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.043
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.043
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.043
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.043
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.043
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.041
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.041
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.041
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.041
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.040
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.040
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.040
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.039
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.039
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.039
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.039
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.039
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.038
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.038
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.038
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.038
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.038
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.038
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.038
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.037
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.037
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.037
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.037
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.037
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.037
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.037
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.036
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.036
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.036
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.036
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.036
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.036
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.035
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.035
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.035
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.035
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.035
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.035
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.035
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.035
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.035
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.035
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.034
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.034
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.034
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.034
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.034
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.033
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.033
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.033
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.033
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.033
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.033
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.033
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.033
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.032
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.032
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.032
|
|
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.032
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.032
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.032
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.032
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.032
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.032
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.032
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.031
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.031
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.031
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.031
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.031
|
Mouse |
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.031
|
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.031
|
|
|
|
purkinje myocyte development
|
GO:0003165 |
1 |
0.030
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.030
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.030
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.030
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.030
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.030
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.030
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.029
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.029
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.029
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.029
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.028
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.028
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.028
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.028
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.028
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.028
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.028
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.027
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.027
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.027
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.027
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.027
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.027
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.027
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.027
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.027
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.027
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.027
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.026
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.026
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.026
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.026
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.026
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.026
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.026
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.026
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.025
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.025
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.025
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.025
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.025
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.025
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.025
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.025
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.024
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.024
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.024
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.024
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.024
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.024
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.024
|
|
|
|
establishment of glial blood brain barrier
|
GO:0060857 |
2 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.024
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.024
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.023
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.023
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.023
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.023
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.023
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.023
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.023
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.023
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.023
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.023
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.023
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.023
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.023
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.022
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.022
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.022
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.022
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.022
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.022
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.022
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.022
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.022
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.022
|
|
|
|
glial cell fate specification
|
GO:0021780 |
5 |
0.022
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.022
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.022
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.022
|
|
|
|
regulation of glutamate secretion
|
GO:0014048 |
3 |
0.021
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.021
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.021
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.021
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.021
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.021
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.021
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.021
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.021
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.021
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.021
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.021
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.021
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.021
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.021
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.021
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.021
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.021
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.021
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.021
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.020
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.020
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.020
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.020
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.020
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.020
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.020
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.020
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.020
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.020
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.020
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.020
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.019
|
|
|
|
spinal cord patterning
|
GO:0021511 |
25 |
0.019
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.019
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.019
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.019
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.019
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.019
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.019
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.019
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.019
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.019
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.019
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.019
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.019
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.019
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.018
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.018
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.018
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.018
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.018
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.018
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.018
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.018
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.018
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.018
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.018
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.018
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.018
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.018
|
Mouse |
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.018
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.018
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.018
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.018
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.018
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
Mouse |
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.018
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.018
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.018
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.018
|
|
|
|
regulation of long term synaptic depression
|
GO:1900452 |
3 |
0.018
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.017
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.017
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.017
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.017
|
Mouse |
|
|
regulation of protein depolymerization
|
GO:1901879 |
26 |
0.017
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.017
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.017
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.017
|
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.017
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.017
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.017
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.017
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.017
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.017
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.017
|
|
|
|
spinal cord dorsal ventral patterning
|
GO:0021513 |
23 |
0.017
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.017
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.017
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.016
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.016
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.016
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.016
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.016
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.016
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.016
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.016
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.016
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.016
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.016
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.016
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.016
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.016
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.016
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.016
|
|
|
|
male genitalia morphogenesis
|
GO:0048808 |
4 |
0.016
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.016
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
36 |
0.016
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.016
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.016
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.016
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.016
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.016
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.016
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.016
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.015
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.015
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.015
|
|
|
|
positive regulation of cation channel activity
|
GO:2001259 |
8 |
0.015
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.015
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.015
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.015
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.015
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.015
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.015
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.015
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.015
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.015
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.015
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.015
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.015
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.015
|
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
35 |
0.015
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.015
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.015
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.015
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.015
|
Mouse |
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.015
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.015
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.015
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.015
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.015
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.015
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.015
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.015
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.015
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.015
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.015
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.015
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.015
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.015
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.014
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.014
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.014
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.014
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.014
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.014
|
|
|
|
positive regulation of amino acid transport
|
GO:0051957 |
4 |
0.014
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.014
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.014
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.014
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.014
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.014
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.014
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.014
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.014
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.014
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.014
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.014
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.014
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.014
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.014
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.014
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.014
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.014
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.014
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.014
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.014
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.014
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.014
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.014
|
|
|
|
endothelial tube morphogenesis
|
GO:0061154 |
2 |
0.014
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.014
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.014
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.014
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.014
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.014
|
|
|
|
positive regulation of glutamate secretion
|
GO:0014049 |
2 |
0.013
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.013
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.013
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.013
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.013
|
|
|
|
cardiac muscle cell apoptotic process
|
GO:0010659 |
10 |
0.013
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.013
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.013
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.013
|
|
|
|
phototransduction
|
GO:0007602 |
17 |
0.013
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.013
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.013
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.013
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.013
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.013
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.013
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.013
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.013
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.013
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.013
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.013
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.013
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.013
|
|
|
|
oligodendrocyte cell fate commitment
|
GO:0021779 |
5 |
0.013
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.013
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.013
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.013
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.013
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.013
|
|
